RVL Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Equivalents	19.16	44.54	40.44	114.05	95.87	70.83
Cash & Short-Term Investments	19.16	44.54	40.44	114.05	95.87	70.83
Cash Growth	-30.11%	10.13%	-64.54%	18.97%	35.34%	103.88%
Accounts Receivable	1	0.95	-	0.25	43.91	56.42
Other Receivables	0.93	2.08	2.13	2.9	-	-
Receivables	1.93	3.03	2.13	3.15	43.91	56.42
Inventory	1.36	0.78	0.84	1.83	21.31	24.38
Prepaid Expenses	3.31	8.62	12.9	12.59	11.55	20.72
Other Current Assets	-	-	3.06	41.53	-	-
Total Current Assets	25.75	56.98	59.38	173.15	172.63	172.36
Property, Plant & Equipment	3.81	1.79	2.23	4.34	35.22	31.26
Goodwill	55.85	55.85	55.85	55.85	100.86	100.86
Other Intangible Assets	-	13.9	27.21	35.09	153.99	490.39
Other Long-Term Assets	-	-	-	102.51	0.56	0.75
Total Assets	85.4	128.51	144.67	370.95	463.26	795.62
Accounts Payable	2.53	2.41	3.78	3.13	8.5	24.87
Accrued Expenses	6.81	13.47	13.01	16.86	31.02	37.95
Current Portion of Long-Term Debt	57.75	1.43	2.41	-	-	1.77
Current Portion of Leases	0.21	0.45	0.84	1.22	2.19	0.12
Current Income Taxes Payable	0.05	0.04	0	0	-	-
Current Unearned Revenue	1.05	1.92	0.07	-	-	0.1
Other Current Liabilities	-	-	-	34.58	34.23	49.18
Total Current Liabilities	68.39	19.72	20.11	55.78	75.94	114
Long-Term Debt	-	55.5	43.8	219.53	267.95	266.8
Long-Term Leases	0.19	0.11	0.59	0.87	3.16	0.14
Long-Term Deferred Tax Liabilities	0.03	0.06	0.15	0.35	1.5	28.29
Other Long-Term Liabilities	0.47	2.02	3.29	0.57	-	2.54
Total Liabilities	69.08	77.42	67.94	277.09	348.55	411.78
Common Stock	0.99	0.99	0.83	0.63	0.52	0.53
Additional Paid-In Capital	620.06	619.32	591.73	548.07	489.44	487.29
Retained Earnings	-604.72	-569.22	-517.53	-452.61	-373.02	-102.12
Comprehensive Income & Other	-	-	1.7	-2.23	-2.23	-1.85
Shareholders' Equity	16.33	51.09	76.73	93.86	114.71	383.85
Total Liabilities & Equity	85.4	128.51	144.67	370.95	463.26	795.62
Total Debt	58.15	57.49	47.65	221.62	273.3	268.83
Net Cash (Debt)	-38.99	-12.95	-7.2	-107.56	-177.43	-198
Net Cash Per Share	-0.40	-0.14	-0.11	-1.77	-3.39	-4.37
Filing Date Shares Outstanding	99.54	99.35	83.52	62.72	58.9	52.52
Total Common Shares Outstanding	99.39	99.16	83.3	62.55	51.85	52.52
Working Capital	-42.64	37.25	39.27	117.37	96.69	58.36
Book Value Per Share	0.16	0.52	0.92	1.50	2.21	7.31
Tangible Book Value	-39.52	-18.65	-6.32	2.92	-140.13	-207.4
Tangible Book Value Per Share	-0.40	-0.19	-0.08	0.05	-2.70	-3.95
Land	-	-	-	-	2.12	2.12
Buildings	-	-	-	-	11.64	11.57
Machinery	-	1.34	1.31	2.28	25.93	22.28
Construction In Progress	-	0.7	0.07	0.03	1.41	3.42
Leasehold Improvements	-	0.39	1.13	2.21	3.42	2.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.